Study found the hormone-lowering effect to be independent of weight loss
Feb. 25, 2016
| By Kristen Woodward / Fred Hutch News Service
A Fred Hutch study involving postmenopausal, overweight and obese women who took 2,000 IUs of vitamin D daily for a year found that those whose vitamin D blood levels increased the most had the greatest reductions in blood estrogens, which are a known risk factor for breast cancer.
Seminal study found significantly higher risk of heart disease, stroke, breast cancer from combined hormone replacement therapy; as a result, 15,000-20,000 fewer breast cancer cases each year
June 25, 2012
| By Rachel Tompa
July marks the 10th anniversary of the WHI's first publication describing the risks of combination hormone therapy. That paper, published in the Journal of the American Medical Association, has singularly changed the face of women's medicine around the world. Researchers estimate that because of the decrease in hormone therapy use following the WHI publication, there have been 15,000-20,000 fewer cases of breast cancer each year in the United States.
Dr. Anne McTiernan finds lifestyle changes lower blood estrogen levels in overweight and obese postmenopausal women, may reduce risk of most common breast cancers
May 29, 2012
| By Kristen Woodward
Even a moderate amount of weight loss can significantly reduce levels of circulating estrogens that are associated with an increased risk of breast cancer, according to a study by Fred Hutchinson Cancer Research Center researchers—the first randomized, controlled clinical trial to test the effects of weight loss on sex hormones in overweight and obese postmenopausal women, a group at elevated risk for breast cancer.
Anne McTiernan's $250,000 grant extends her vitamin D work; Jamie Guenthoer to develop early detection blood test with $180,000 award
May 29, 2012
Drs. Anne McTiernan and Jamie Guenthoer of the Fred Hutchinson Cancer Research Center recently garnered grants from Susan G. Komen for the Cure, part of the organization's $58 million in new research funding for 2012.